Impact of direct sirolimus-eluting stent implantation on the early systemic inflammatory response compared with complementary stent implantation

Coronary Artery Disease

Volumn 20, Issue 1, 2009, Pages 65-70

  Li, Jian Jun ^a   Zhang, Yu Ping ^b   Wang, Chun ^c   Gao, Li Jian ^a   Qin, Xue Wen ^a   Xu, Bo ^a   Chen, Ji Lin ^a   Yang, Yue Jin ^a   Gao, Run Lin ^a  

^a FUWAI HOSPITAL   (China)

^b Changzhi People's Hospital   (China)

^c PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

Author keywords

Coronary artery disease; Inflammation; Sirolimus eluting stent

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; RAPAMYCIN; TROPONIN I;

ADULT; ARTICLE; BLOOD SAMPLING; BLOOD VESSEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ELUTING STENT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; INTERMETHOD COMPARISON; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; STABLE ANGINA PECTORIS;

ADULT; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; SIROLIMUS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTORS; TREATMENT OUTCOME; TROPONIN I; UP-REGULATION;

EID: 58149267876     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32830d27bd     Document Type: Article

References (32)

1. Versaci F, Gaspardone G. Prevention of restenosis after stenting: the emerging role of inflammation. Coron Artery Dis 2004; 15:307-311.
2. Gaspardone G, Versaci F. Coronary Stenting and inflammation. Am J Cardiol 2005; 96 (supp I):65L-70L
3. Li JJ, Li Z, Li J. Is inflammation a contributor for in-stent restenosis? Med Hypotheses 2007; 68:945-951.
4. Gibson CM, Karmpaliotis D, Kosmidou I, Murphy SA, Kirtane AJ, Budiu D, et al. Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaenous coronary intervention for non-ST-elevation acute coronary syndrome. Am J Cardiol 2006; 97:1473-1477.
5. Kim JY, Ko YG, Shim CY, Park S, Hwang KC, Choi D, et al. Comparison of effects of drug-eluting stents versus bare metal stents on plasma C-reactive protein levels. Am J Cardiol 2005; 96:1384-1388.
6. Li JJ, Li J, Nan JL, Li Z, Zhen X, Mu ZW, et al. Coronary restenosis reduction of drug-eluting stent may be due to its anti-inflammatory effects. Med Hypotheses 2007; 69:1004-1009.
7. Li JJ. Early, intensive and long-term statin therapy in acute coronary syndrome: focus on an anti-inflammatory mechanism. Vasc Dis Prevent 2005; 2:181-186.
8. Hojo Y, Ikeda U, katsuki T, Mizuno O, Fukazawa H, Kurosaki K, et al. Interleukin-6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart 2000; 84:83-87.
9. Salen N, Tornvall P. Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis. Atherosclerosis 2007; 195:374-378.
10. Barbato E, Marco J, Wijns W. Direct stenting. Eur Heart J 2003; 24:394-403.
11. Briguori C, Sheiban I, De Gregorio J, Anzuini A, Montorfano M, Pagnotta P, et al. Direct coronary stenting without predilatation. J Am Coll Cardiol 1999; 34:1910-1915.
12. Bass TA. Direct stenting in the DES era: can we do better? Catheter Cardiovasc Interv 2007; 70:513-514.
13. Larrazet F, Philippe E, Caussin C, Lancelin R, Aptecer E, Pernes JM, et al. Feasibility, safety, cost-effectiveness and 1 year follow-up of coronary stenting without predilatation: a matched comparison with the standard approach. Int J Cardiol 2001; 80:187-192.
14. Carrie D, Khalife K, Citron B, Izaaz K, Hamon M, Juiliard JM, et al. Comparison of direct coronary stenting with and without balloon predilatation in patients with stable angina pectoris. BET (Benefit Evaluation of Direct Coronary Stenting) Study Group. Am J Cardiol 2001; 87:693-698.
15. Brito FS Jr, Caixeta AM, Perin MA, Rati M, Arruda JA, Cantarelli M, et al. Comparison of direct stenting versus stenting with predilatation for the treatment of selected coronary narrowings. Am J Cardiol 2002; 89:115-120.
16. Moses JW, Weisz G, Mishkel G, Caputo R, O'Shaughnessey C, Wong SC, et al. The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coornary artery lesions. Catherter Cardiovasc Interv 2007; 70:505-512.
17. Li JJ, Xu B, Yang YJ, Chen JL, Qiao SB, Ma WH, et al. Is there delayed restenosis in patients with coronary artery disease treated with sirolimus-eluting stent?. Coron Artery Dis 2007; 18:293-298.
18. Li JJ, Fang CH, Jiang H, Huang CX, Hui RT, Chen MZ. Time course of inflammatory response after renal artery stenting in patients with atherosclerotic renal artery stenosis. Clin Chim Acta 2004; 350:115-121.
19. Danzi GB, Capuano C, Fiocca L, Dallavalle F, Pirelli S, Mauri L, Quaini E. Stent implantation without predilatation in patients with a single, noncalcified coronary artery lesion. Am J Cardiol 1999; 84:1250-1253.
20. Le Breton H, Boschat J, Commeau P, Brunel P, Gilard M, Breut C, et al. Randomized comparison of coronary stenting with and without balloon predilatation in selected patients. Heart 2001; 86:302-308.
21. Ijsselmuiden AJJ, Serruys PW, Scholte A, Kiemeneij F, Slagboom T, vd Wieken LR, et al. Direct coronary stent implantation does not reduce the incidence of in-stent restenosis or major adverse cardiac events. Eur Heart J 2003; 24:421-429.
22. Elbaz M, El Mokhtar E, Khakife K, Citron B, Izaaz K, Hamon M, et al. Is direct coronary stenting the best strategy for long-term outcome? Results of the multicentric randomized benefit evaluation of direct coronary stenting (BET) study. Am Heart J 2002; 144:E7.
23. Pentousis D, Guerin Y, Funck F, Zhang H, Toussaint M, Corcos T, Favereau X. Direct stent implantation without predilatation using the MultiLink stent. Am J Cardiol 1998; 82:1437-1440.
24. Herz I, Assali A, Solodky A, Shor N, Ben-Gal T, Adler Y, Birnbaum Y. Coronary stent deployment without predilatation in acute myocardial infarction: a feasible, safe, and effective technique. Angiology 1999; 50:901-908.
25. Brueck M, Scheinert D, Wortmann A, Bremer J, von Kom H, Klinghammer L, et al. Direct coronary stenting versus predilatation followed by stent placement. Am J Cardiol 2002; 90:1187-1192.
26. Burzotta F, Trani C, Prati F, Hamon M, Mazzari MA, Mongiardo R, et al. Comparison of outcomes (early and six-month) of direct stenting with conventional stenting (a meta-analysis of ten randomized trials). Am J Cardiol 2003; 91:790-796.
27. Bairn DS, Flatley M, Caputo R, O'Shaughnessy C, Low R, Fanelli C, et al. Comparison of pre-dilatation vs direct stenting in coronary treatment using the Medtronic AVE S670 coronary stent system (the PREDICT trial). Am J Cardiol 2001; 88:1364-1369.
28. Costa MA, Angiolillo DJ, Kuehl W. Impact of deployment techniques in the drug-eluting stent era: early results from the STLLR trial. Catheter Cardiovasc Diagn 2005; 65:C11.
29. Silber S, Hamburger J, Grube E, Pfisterer M, Belardi J, Webb J, et al. Direct stenting with TAXUS stents seems to be as safe and effective as with predilatation. Herz 2004; 29:171-180.
30. Schluter M, Schofer J, Gershlick AH, Schampaert E, Wijns W, Breithardt G, et al. Direct stenting of native de novo coronary artery lesions with the sirolimus-eluting stent: a post hoc subanalysis of the pooled E- and C-SIRIUS trials. J Am Coll Cardiol 2005; 45:10-13.
31. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Nolmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349:1315-1323.
32. Sardella G, Mariani P, D'Alessandro M, De Luca L, Pierro M, Mancone M, et al. Early elevation of interteukin-ibeta and interleukin-6 levels after bare or drug-eluting stent implantation in patients with stable angina Thromb Res 2006; 117:659-664.